Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-26

Clinical Trial Update: Comparision of the Analgesic Effects of Intravenous Ibuprofen and Tenoxicam in Acute Migraine Attack [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing analgesic effects of intravenous ibuprofen and tenoxicam for acute migraine; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)
  • Tenoxicam (tenoxicam)

Snippet

Sponsor: Haydarpasa Numune Training and Research Hospital | Conditions: Migraine, Analgesic Affect | Phase 4 | Status: ACTIVE_NOT_RECRUITING